Sg Americas Securities, LLC Editas Medicine, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 40,096 shares of EDIT stock, worth $96,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,096
Holding current value
$96,631
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$3.39 - $5.96 $135,925 - $238,972
40,096 New
40,096 $137,000
Q4 2023

Jan 12, 2024
SELL
$6.25 - $11.11 $111,793 - $198,724
-17,887 Reduced 35.25%
32,859 $333,000
Q3 2023

Oct 13, 2023
BUY
$6.92 - $9.31 $351,162 - $472,445
50,746 New
50,746 $396,000
Q1 2023

Apr 28, 2023
BUY
$7.03 - $11.53 $73,969 - $121,318
10,522 New
10,522 $76,000
Q3 2022

Oct 31, 2022
SELL
$12.16 - $19.42 $321,595 - $513,600
-26,447 Reduced 51.95%
24,459 $299,000
Q2 2022

Jul 29, 2022
BUY
$9.99 - $21.35 $129,790 - $277,379
12,992 Added 34.27%
50,906 $602,000
Q1 2022

Apr 29, 2022
BUY
$14.08 - $27.63 $533,829 - $1.05 Million
37,914 New
37,914 $721,000
Q4 2021

Feb 07, 2022
SELL
$26.55 - $40.57 $373,558 - $570,819
-14,070 Closed
0 $0
Q3 2021

Nov 01, 2021
BUY
$39.27 - $72.94 $453,136 - $841,654
11,539 Added 455.91%
14,070 $578,000
Q2 2021

Aug 12, 2021
SELL
$31.29 - $56.64 $322,975 - $584,638
-10,322 Reduced 80.31%
2,531 $143,000
Q1 2021

May 13, 2021
BUY
$39.71 - $90.58 $162,612 - $370,925
4,095 Added 46.76%
12,853 $540,000
Q4 2020

Feb 04, 2021
SELL
$27.07 - $84.35 $580,407 - $1.81 Million
-21,441 Reduced 71.0%
8,758 $614,000
Q3 2020

Nov 09, 2020
BUY
$28.06 - $37.16 $120,433 - $159,490
4,292 Added 16.57%
30,199 $847,000
Q2 2020

Jul 20, 2020
BUY
$18.5 - $34.34 $271,173 - $503,355
14,658 Added 130.3%
25,907 $766,000
Q1 2020

Apr 30, 2020
BUY
$14.88 - $32.78 $108,103 - $238,146
7,265 Added 182.35%
11,249 $223,000
Q4 2019

Jan 28, 2020
BUY
$19.49 - $32.63 $77,648 - $129,997
3,984 New
3,984 $118,000
Q3 2018

Nov 06, 2018
SELL
$27.65 - $38.39 $85,355 - $118,509
-3,087 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$31.4 - $41.01 $217,256 - $283,748
-6,919 Reduced 69.15%
3,087 $111,000
Q1 2018

May 03, 2018
BUY
$29.84 - $44.08 $298,579 - $441,064
10,006 New
10,006 $332,000

Others Institutions Holding EDIT

# of Institutions
247
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $166M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email